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Chronic respiratory diseases other than lung cancer that are of
occupational or environmental origin, along with cigarette smoking,
account for over 100,000 deaths per year and are among the leading
causes ofrespiratory disability in the United States and throughout
the world. Lung cancer from these same exposures may account for
40,000 additional deaths per year. In spite ofcigarette smoking's
being recognized as the leading cause ofboth chronic obstructive pul-
monary disease (COPD) and lung cancer, many other environmental
and occupational exposures have been implicated as directly or indi-
rectly associated with smoking in producing these diseases. In addi-
tion, the burden ofdisease is not uniformly distributed across the
U.S. population. Furthermore, recognition ofthese associations with
environmental and occupational exposures has done little in the last
20 years to reduce the burden ofthese respiratory conditions at the
population level.
COPD is the fourth leading cause ofdeath in this country and,
with asthma, accounts for one ofthe major categories ofhealth care
expenditure by whatever criteria are used. While the role ofcigarette
smoking is well characterized in these diseases as is the overwhelming
role ofsmoking as the major cause oflung cancer, the identification
ofresearch objectives that could lead to strategies for lessening the
burden ofoccupational and environmental causes ofthese chronic
respiratorydiseases iswell worthwhile.
For manyyears efforts to establish the number ofpeople at risk in
occupational settings have used estimates ofemployed and retired
work forces in industries with known putative respiratory exposures.
Often for legitimate reasons, developing these numbers has been
extremelydifficult, and thus the estimates are crude. Nevertheless, the
National Institute for Occupational Safety and Health data suggest
that over 20 million Americans are exposed to potential respiratory
hazards in the workplace. Table 1 summarizes crude estimates of
some of the major agents and industries in which exposures are
known to occur. None ofthese exposures would be surprises to either
the scientific community or the laypublic, yet they continue to occur.
Added to these numbers is the potential for over 100 million citizens
to be exposed to environmental irritants from primary air pollutants
that exceed the National Air QualityStandards first established by the
U.S. Environmental Protection Agency in 1971 in many parts ofthe
country at leastseveral times peryear.
We approached this important topic by taking the view that it is
critical to first understand the pathophysiologic, biologic, and general
epidemiologic approaches that might be invoked in studying these
diseases. Second, we explored the major environmental and occupa-
tional exposure patterns within the U.S. population. Finally, we
selected the disease outcomes known to be associatedwith these expo-
sures and asked experts to provide a selected review ofthe state of
knowledge, to identify the important gaps in our knowledge, and to
suggest avenues ofresearch for the next 5-7 years.
This effort brought together awide variety ofknowledgeable scien-
tists with diverse expertise from basic science to clinical applications
and population sciences. Although each manuscript in this monograph
was produced independently, all authors had a common objective.
Table 1. Selected agents and industries with potential for respiratory hazard exposure.
Estimated number of Chronic
Agent Industry persons exposed respiratory disease Estimated risk
Asbestos Construction, manufacturing, and - 250,000 primary processing, Pulmonaryfibrosis, obstructive Asbestosis: 10-50%,
mining ofasbestos and related materials 3 x 106 in secondary processing airway disease, lung cancer lung cancer: 1-10%
Silica Mining, stone cutting, construction, 1.2 x 106 in nonagriculture Pulmonaryfibrosis, silicosis 0-13%
farming, quarrying
Cotton dust Cotton mills 800,000 Chronic bronchitis, reduced 2-30%
pulmonaryfunction,
bysinosis
Coal dust Coal mining 200,000 Pulmonary fibrosis, 4-46%
pneumoconiosis
Known chemical Widevariety of industries >9 x 106 Occupational asthma Up to 28% of adult
and biologic sensitizers asthma
Grain dust Elevator agents, dockworkers, 500,000 Occupational asthma, COPD Up to 30% in non-
longshoremen, mill workers, chronic bronchitis smokers, perhaps
bakers up to 60% in
smokers
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This monograph is divided into three parts. The first describes
some ofthe methods currently being used to study these diseases. In
the second part, experts consider issues related to exposure to specific
pollutants. The third calls on different experts to consider the com-
mon environmental and occupational diseases. This format ofneces-
sity leads to overlap, which was intentional. We chose to take
advantage ofslightly different perspectives brought to bear on a num-
ber ofthe topics covered. We would like to emphasize that all manu-
scripts submitted to Environmental Health Perspectives undergo peer
review, including manuscripts in this monograph.
The reviews ofeach ofthe environmental and/or occupational set-
tings arebroadandclearlyindicate the need forconsiderable research to
fully understand the nature ofthe putative exposures and the strategies
that might reduce the burden ofthese diseases. The recommendations
for research contained in each review represent the judgment ofthe
reviewer; however, somebroadsummarystatements seemwarranted.
With regard to a better understanding ofexposure, clearly better
measurement ofchronic low levels ofexposure across the range of
environmental agents being considered would provide investigators
with much-needed insight into the relation between exposure and
chronic disease. These measurements need to be both broadly made
and uniformly recorded and archived so they can be assessed in rela-
tion to potentially exposed population groups and, on an individual
level, confirmedwith biomarker data thatwill reflect chronic exposure.
Models also need to be developed to assess the impact ofmixtures of
exposure, whether they are mixtures ofmultiple dusts, particles, and
gases; allergens and nonallergenic materials; or specific chemical forms
orelements ofenvironmental andoccupational agents.
We must improve our understanding ofthe pathophysiologic
mechanisms ofdisease development. Through the use ofanimal mod-
els, detailed physiologic studies, human exposure studies, and
prospective epidemiologic studies designed to test mechanistic
hypotheses, we should be able to develop strategies by which mecha-
nisms can be identified. Interactions between host susceptibility and
environmental or occupational exposures need to be explored in terms
ofgene-environment interactions. In addition, environment-host
interactions that are altered by growth ofthe developing lung, aging
ofthe lung, and changes in defense mechanisms resulting from smok-
ing, infection, dietaryfactors, and thelike must be considered.
An important aspect, unrelated to direct efforts ofexposure in the
lung, is the airways and lungs acting as portals ofentrywith potential
direct or reflex effects on other organ systems. The classic occupa-
tional example is carbon disulfide exposure in the textile industry
and the risk ofcardiovascular disease. More recently efforts to under-
stand the potential mechanisms underlying the observations ofexcess
cardiovascular events associated with ambient environmental expo-
sures have led to physiologic studies in animals, controlled clinical
exposure studies, and population-based studies. In these studies the
concepts ofthe lungs as a portal ofentry for the direct transport of
particles through the lung to the systemic circulation as well as
potential cytokine release and autonomic nervous system stimulation
are all being explored. Inherent in these efforts are a number of
hypotheses relating mortality to lung disease mechanisms but also
systemic responses and how these might be infringed upon ofgene-
environment interactions.
Absent from this exercise is a research agenda on abatement of
these recognized exposures. This lack may be the result ofthe selec-
tion process bywhich the experts were chosen and charged to develop
aresearch agenda for the next 5-7 years. Wehope that byimplement-
ingsuggestions made by these authorswewill learn things thatwill be
applicable to the development ofabatement strategies to reduce the
burden ofthese diseases.
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